Back
ProShares UltraShort Consumer Discretionary Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
19
SCC
ProShares UltraShort Consumer Discretionary
Last Price:
$14.00
Seasonality Move:
-3.14%
Sell
37
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.15
Seasonality Move:
0.37%
Sell
19
ProShares UltraShort Consumer Discretionary (SCC)
is a Sell
Is ProShares UltraShort Consumer Discretionary a Buy, Sell or Hold?
-
The current ProShares UltraShort Consumer Discretionary [SCC] share price is $13.93. The Score for SCC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
SCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.61. The Score for AMPH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCC Stock Price Chart
What is ProShares UltraShort Consumer Discretionary's stock price today?
-
The ProShares UltraShort Consumer Discretionary share price today is $13.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCC is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing slight selling pressure.
SCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 36.97 | Sell |
| Chaikin Money Flow: | -5169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.26 | Sell |
| Chaikin Money Flow: | -108584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.65 - 27.27) | Sell |
| Bollinger Bands (100): | (23.82 - 28.88) | Sell |
SCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.38 | Sell |
| 20-day SMA: | 15.02 | Sell |
| 50-day SMA: | 14.92 | Sell |
| 200-day SMA: | 17.9 | Sell |
| 8-day EMA: | 14.32 | Sell |
| 20-day EMA: | 14.67 | Sell |
| 50-day EMA: | 14.95 | Sell |
| 200-day EMA: | 17.34 | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.9 | Sell |
| 20-day SMA: | 26.41 | Sell |
| 50-day SMA: | 25.48 | Buy |
| 200-day SMA: | 25.65 | Sell |
| 8-day EMA: | 25.99 | Sell |
| 20-day EMA: | 26.16 | Sell |
| 50-day EMA: | 26.06 | Sell |
| 200-day EMA: | 27.93 | Sell |
ProShares UltraShort Consumer Discretionary Earnings Growth & SCC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
ProShares UltraShort Consumer Discretionary Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||